[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CmaxInsight Market Intelligence: Market Research Reports

CmaxInsight is a global pharma consulting firm that specialized in providing high-value customized business research, intelligence reports, and databases across pharmaceutical and healthcare domain. Our aim is to provide insight with intelligence which assists the clients in decision making and to address new challenges in a fast-paced healthcare environment.

We empower healthcare organization at every stage to make the process rapid, better and accurate. We help our clients in bridging the gaps in their business through screening, prioritization, in-depth commercial assessment, independent evaluation of opportunities which facilitating decision-making; identify potential market opportunities, competitor assessments, and business environment assessment.

Publications found: 1,696
Sort by:

Ewing Sarcoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Ewing Sarcoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Ewing Sarcoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Fallopian Tube Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Fallopian Tube Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Fallopian Tube Cancer for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Follicular Thyroid Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Follicular Thyroid Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Follicular Thyroid Cancer for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Gallbladder Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Gallbladder Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Gallbladder Cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Gastric Adenocarcinoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Gastric Adenocarcinoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Gastric Adenocarcinoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Gastric Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Gastric Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Gastric Cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Gastrointestinal Stromal Tumor (GIST): Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Gastrointestinal Stromal Tumor (GIST): Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Gastrointestinal Stromal Tumor (GIST) for the seven major markets i.e., United States, EU5 ...

February 2019 100 pages

Glioblastoma Multiforme (GBM): Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Glioblastoma Multiforme (GBM): Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Glioblastoma Multiforme (GBM) for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Glioma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Glioma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Glioma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Hairy Cell Leukemia: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

... Hairy Cell Leukemia: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Hairy Cell Leukemia for the seven major markets ... potential of the market. Hairy Cell Leukemia Market Trends and Opportunities Identify market trends and the opportunities ...

February 2019 100 pages

Head and Neck Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

... Head and Neck Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Head and Neck Carcinoma for the seven major markets ... potential of the market. Head and Neck Carcinoma Market Trends and Opportunities Identify market trends and the ...

February 2019 100 pages

Hepatocellular Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Hepatocellular Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Hepatocellular Carcinoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Hodgkin lymphoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Hodgkin lymphoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Hodgkin lymphoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Indolent Lymphoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Indolent Lymphoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Indolent Lymphoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Kaposi Sarcoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Kaposi Sarcoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Kaposi Sarcoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Larynx Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Larynx Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Larynx Cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Lip and Oral Cavity Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

... best opportunities for Lip and Oral Cavity Cancer in US, Europe and Japan. To understand the future market competition in the global Lip and Oral Cavity Cancer and insightful review ...

February 2019 100 pages

Liver cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Liver cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Liver cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Liposarcoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Liposarcoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Liposarcoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Lung cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Lung cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Lung cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Malignant Glioma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Malignant Glioma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Malignant Glioma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Malignant Mesothelioma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Malignant Mesothelioma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Malignant Mesothelioma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Mantle Cell Lymphoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Mantle Cell Lymphoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Mantle Cell Lymphoma for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Medullary Thyroid Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Medullary Thyroid Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Medullary Thyroid Cancer for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Medulloblastoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Medulloblastoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Medulloblastoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Merkel Cell Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Merkel Cell Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Merkel Cell Carcinoma for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Metastatic Hepatocellular Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Metastatic Hepatocellular Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Metastatic Hepatocellular Carcinoma for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Metastatic Prostate Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Metastatic Prostate Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Metastatic Prostate Cancer for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Metastatic Renal Cell Carcinoma (mRCC): Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

... the best opportunities for Metastatic Renal Cell Carcinoma (mRCC) in US, Europe and Japan. To understand the future market competition in the global Metastatic Renal Cell Carcinoma (mRCC) and insightful review of the ...

February 2019 100 pages

Multiple Myeloma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Multiple Myeloma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Multiple Myeloma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Nasopharyngeal Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Nasopharyngeal Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Nasopharyngeal Cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Neuroblastoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Neuroblastoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Neuroblastoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Neuroendocrine Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Neuroendocrine Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Neuroendocrine Carcinoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Non-Hodgkin lymphoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Non-Hodgkin lymphoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Non-Hodgkin lymphoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Non-Small Cell Lung Cancer (NSCLC): Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

... the best opportunities for Non-Small Cell Lung Cancer (NSCLC) in US, Europe and Japan. To understand the future market competition in the global Non-Small Cell Lung Cancer (NSCLC) and insightful review of the ...

February 2019 100 pages

Oropharyngeal Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Oropharyngeal Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Oropharyngeal Cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Oligodendroglioma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Oligodendroglioma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Oligodendroglioma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Osteosarcoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Osteosarcoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Osteosarcoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Ovarian Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Ovarian Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Ovarian Cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Pancreatic cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Pancreatic cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Pancreatic cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Pancreatic Endocrine Tumor: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Pancreatic Endocrine Tumor: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Pancreatic Endocrine Tumor for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Peripheral T-Cell Lymphomas (PTCL): Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Peripheral T-Cell Lymphomas (PTCL): Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Peripheral T-Cell Lymphomas (PTCL) for the seven major markets i.e., United States, EU5 ...

February 2019 100 pages

Oral and Pharyngeal Cancers: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Oral and Pharyngeal Cancers: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Oral and Pharyngeal Cancers for the seven major markets i.e., United ...

February 2019 100 pages

Poly-cythemia Vera: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Poly-cythemia Vera: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Poly-cythemia Vera for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Prostate Cancer: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Prostate Cancer: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Prostate Cancer for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Recurrent Head and Neck Cancer Squamous Cell Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

... guidelines for Recurrent Head and Neck Cancer Squamous Cell Carcinoma in the United States, Europe, and Japan are also covered. Recurrent Head and Neck Cancer Squamous Cell ...

February 2019 100 pages

Recurrent Malignant Glioma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Recurrent Malignant Glioma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Recurrent Malignant Glioma for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Renal Cell Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Renal Cell Carcinoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Renal Cell Carcinoma for the seven major markets i.e., United States, EU5 (France ...

February 2019 100 pages

Retinoblastoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Retinoblastoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Retinoblastoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Rhabdomyosarcoma: Market Assessment, Epidemiology & Market Forecast-2028

US$ 4,500.00

CmaxInsight’s “Rhabdomyosarcoma: Market Assessment, Epidemiology & Market Forecast-2028” report provides an overview of the disease and market size of Rhabdomyosarcoma for the seven major markets i.e., United States, EU5 (France, Germany ...

February 2019 100 pages

Filters

Search

Categories

1,696

Publishers

1,696

Regions

1,696

Price

Date

Pages

Offers